(EMAILWIRE.COM, February 05, 2019 ) This cell expansion market is driven by several factors such as increasing government funding for research, high prevalence of chronic diseases, rising company investments for development of cell-based products, and growing number of GMP-certified production facilities. High potential growth in emerging markets has opened an array of opportunities for the cell expansion market.

However, high cost of cell-based research and ethical concerns are hampering the growth of the global cell expansion market.

Download PDF: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=194978883

* Increasing incidences of these diseases is a key factor contributing to the growth of the cell expansion market

Cell expansion is used in the research and development of drugs for the treatment of diseases. It is used in the production of vaccines, drugs, therapeutics, and antibiotics. The rising incidence of diseases such as diabetes and cancer has created a need for conducting extensive research to develop new treatment options. According to the World Health Organization, globally, 347 million people had diabetes in 2013 and it is estimated that diabetes will be the 7th most prevalent disease by 2030.

The major players in this Cell expansion market;

Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Corning, Inc. (U.S.), GE Healthcare (U.K.), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT, Inc. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).

Read More: https://www.marketsandmarkets.com/Market-Reports/cell-expansion-market-194978883.html